|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 31/47 | (2006.01) |
| A61P 1/00 | (2006.01) |
| (11) | Number of the document | 1339407 |
| (13) | Kind of document | T |
| (96) | European patent application number | 01998349.3 |
| Date of filing the European patent application | 2001-11-20 | |
| (97) | Date of publication of the European application | 2003-09-03 |
| (45) | Date of publication and mention of the grant of the patent | 2006-04-19 |
| (46) | Date of publication of the claims translation | 2006-08-25 |
| (86) | Number | PCT/EP2001/013540 |
| Date | 2001-11-20 |
| (87) | Number | WO 2002/043733 |
| Date | 2002-06-06 |
| (30) | Number | Date | Country code |
| 253346 P | 2000-11-28 | US |
| (72) |
END, David, William, US
BOWDEN, Charles, Ronald, US
|
| (73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Farnezilproteintransferazės slopintojai, skirti uždegiminės žarnyno ligos gydymui |
| FARNESYL PROTEIN TRANSFERASE INHIBITORS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE |
| Payment date | Validity (years) | Amount | |
| 2020-10-26 | 347.00 EUR |